Matrixyl (Palmitoyl Pentapeptide-4)
Overview
Matrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.
Key Research Findings
In vitro fibroblast culture studies have documented increased collagen mRNA and protein expression following exposure to palmitoyl pentapeptide-4. Small-scale human trials conducted by cosmetic manufacturers have reported improvements in fine wrinkles and skin firmness after 12 weeks of topical use, though independent validation in peer-reviewed dermatology literature is sparse. Histological evidence of dermal matrix changes in human skin biopsies remains limited.
Topical
Investigational
Interested in Matrixyl (Palmitoyl Pentapeptide-4)?
Find a verified provider experienced with Matrixyl (Palmitoyl Pentapeptide-4) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a Matrixyl (Palmitoyl Pentapeptide-4) ProviderRelated Peptides
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.
Argireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.
Matrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.
Matrixyl Synthe'6 (Palmitoyl Tripeptide-38)
InvestigationalPalmitoyl tripeptide-38 is a synthetic lipopeptide designed to stimulate synthesis of six major constituents of the dermal matrix: collagen I, III, and IV, fibronectin, hyaluronic acid, and laminin 5. It is proposed to activate transforming growth factor beta (TGF-beta) signaling in fibroblasts, thereby promoting coordinated extracellular matrix assembly. The palmitic acid conjugate enhances dermal bioavailability when applied topically.